Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half

Giving trauma patients with severe blood loss the hormone arginine vasopressin (AVP) cut the volume of blood products required to stabilize them by half, according to results of a new, first-of-its-kind clinical trial from Penn Medicine. The authors say the study is particularly important for the treatment of patients with gun-related injuries. Each year, there are over 100,00 firearm-related injuries with over 36,000 deaths.


Click here for original story, Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half


Source: ScienceDaily